In its upcoming report, Phreesia (PHR) is predicted by Wall Street analysts to post quarterly earnings of $0.02 per share, reflecting an increase of 128.6% compared to the same period last year. Revenues are forecasted to be $130.27 million, representing a year-over-year increase of 12.4%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some Phreesia metrics that are commonly tracked and projected by analysts on Wall Street.
Based on the collective assessment of analysts, 'Revenus- Subscription and related services' should arrive at $56.28 million. The estimate points to a change of +3.5% from the year-ago quarter.
It is projected by analysts that the 'Revenus- Network solutions' will reach $33.92 million. The estimate indicates a year-over-year change of +7.1%.
Analysts predict that the 'Revenus- Payment processing fees' will reach $38.22 million. The estimate indicates a change of +27.7% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Average healthcare services Clients' of 4,710 . Compared to the current estimate, the company reported 4,411 in the same quarter of the previous year.
The consensus estimate for 'Patient payment volume' stands at $1.43 billion. Compared to the present estimate, the company reported $1.31 billion in the same quarter last year.
Analysts forecast 'Payment facilitator volume percentage' to reach 84.0%. The estimate compares to the year-ago value of 82.0%.
View all Key Company Metrics for Phreesia here>>>Phreesia shares have witnessed a change of -5% in the past month, in contrast to the Zacks S&P 500 composite's +4.6% move. With a Zacks Rank #3 (Hold), PHR is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Phreesia, Inc. (PHR): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).